Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Proteomics International, inVentiv Health Sign Biosimilar Agreement

Published: Saturday, March 01, 2014
Last Updated: Wednesday, March 12, 2014
Bookmark and Share
Partnership offers developers full service biosimilar expertise on a global scale.

Proteomics International has signed a collaborative agreement with inVentiv Health Clinical. 

Biosimilar and biologic development begins with extensive structural and functional characterization. Proteomics International provides structural characterization and QC testing of proposed and referenced products with an advanced suite of scientific instrumentation. These services complement inVentiv Health’s array of bioanalytical capabilities from clinical development through commercialization in support of biosimilar development. 

The Proteomics International agreement with inVentiv Clinical offers developers the ability to seamlessly transition from characterization to clinical trials thereby streamlining the process and providing a competitive advantage in the race to market. 

“We welcome the partnership with inVentiv as it represents a significant opportunity for us in furthering expansion into bio-generic markets,” said Dr. Richard Lipscombe, Managing Director of Proteomics International. “This collaboration will position both companies to better assist biosimilar and biologics developers in this emerging field and ever-changing regulatory environment.” 

“The strengths of Proteomic International to demonstrate biosimilarity combined with inVentiv biologic clinical, commercial and consulting expertise is a winning solution for clients,” said Dr. George Scott, Vice President, Bioanalytical Services for inVentiv Clinical. “Together we offer the full breadth and scope of an integrated roadmap of biosimilar development services to help navigate the complex regulatory and development landscape from early strategic planning, clinical trial conduct, and registration to commercialization.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Diverse Fungi Secrete Similar Suite of Decomposition Enzymes
A recent study reveals different fungal species secrete a rich set of enzymes that share similar functions, despite species-specific differences in the amino acid sequences of these enzymes.
Misfiring Drugs Hit the Wrong Targets
Anti-HIV protein inhibitor drugs can bind to the wrong protein, causing unwanted side effects.
Spotting Falsified, Degraded Medications
A team of researchers has developed a simple, inexpensive paper-based device to screen suspicious medications.
Comparing Fungal Secretions
Their unassuming appearances may cause them to be overshadowed by the plants or animals in their natural habitats, but fungi play key roles in maintaining their ecosystems.
Ginger Nanoparticles Heal Bowel Disease
Lab team spins ginger into nanoparticles to heal inflammatory bowel disease.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Method To Study Critical HIV Protein Developed
Researchers at Sandia National Laboratories and Northeastern University have developed a new technique to study how a critical HIV protein changes shape.
Mitochondrial Maps Reveal New Connections to Poorly Understood Diseases
Mitochondria are the engines that drive cellular life, but these complex machines are vulnerable to a wide range of breakdowns, and hundreds of their component parts remain a functional mystery.
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!